Paper Review Records
全部论文审稿周期
4 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
49
天
Ocrelizumab Discontinuation vs. Continuation After Safety Events: Comparative Insights from MSBase
作者
Aurora Zanghì; Tim Spelman; Marzena Fabis-Pedrini; William M. Carroll; Helmut Butzkueven; Allan G. Kermode; Jeannette Lechner-Scott; Anneke van der Walt; Emanuele D’Amico; the MSBase Study Group展开收起
作者单位
1. Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy;; 2. Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden;; 3. Perron Institute for Neurological and Translational Science, University of Western Australia, Nedlands, Australia;; 4. Personalised Medicine Centre, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia;; 5. Perron Institute for Neurological and Translational Science, Sir Charles Gairdner Hospital, QEIIMC, The University of Western Australia, Perth, Australia;; 6. Department of Neurology, The Alfred Hospital, Melbourne, Australia;; 7. Department of Neuroscience, School of Translational Medicine, Monash University, Melbourne, Australia;; 8. Hunter Medical Research Institute, University Newcastle, Newcastle, Australia;; 9. Hunter New England Health, John Hunter Hospital, NSW, Australia展开收起
98
天
Repetitive Transcranial Magnetic Stimulation Alters Brain Communication Networks to Improve the Cognitive Function in Patients with Amnestic Mild Cognitive Impairment - A Clinical Trial
作者
Zhiyuan Yang; Moran Tangli; Yi Tan; Haojie Chen; Ni Shu; Zhihong Ke; Zheqi Hu; Qing Ye; Hailan Meng; Haifeng Chen; Yun Xu展开收起
作者单位
1. Department of Neurology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing, China;; 2. State Key Laboratory of Pharmaceutical Biotechnology and Institute of Translational Medicine for Brain Critical Diseases, Nanjing University, Nanjing, China;; 3. Jiangsu Key Laboratory for Molecular Medicine, Medical School of Nanjing University, Nanjing, China;; 4. Nanjing Neurology Clinical Medical Center, Nanjing, China;; 5. State Key Laboratory of Cognitive Neuroscience and Learning & IDG/McGovern Institute for Brain Research, Beijing Normal University, Beijing, China; 6. Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China;; 7. Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China;展开收起
54
天
Efgartigimod in Very-Late-Onset Generalized Myasthenia Gravis: A Real-World Study on Effectiveness and Safety
作者
Chi Ma; Jingyi Shen; Ying Zhu; Benqiao Wang; Ruixia Zhu展开收起
作者单位
1. Department of Neurology, The First Affiliated Hospital of China Medical University, Key Laboratory of Neurological Disease Big Data of Liaoning Province, Shenyang Clinical Medical Research Center for Difficult and Serious Diseases of the Nervous System, Shenyang, China展开收起
107
天
Sleep Disorders in Moyamoya Disease: Prevalence, Risk Factors, and Impact on Functional Outcomes
作者
Qingbao Guo; Manli Xie; Dan Yu; Cong Han; Yuqing Gao; Qian-Nan Wang; Xiangyang Bao; Lian Duan展开收起
作者单位
1. Department of Neurosurgery, Xi'an No.9 Hospital, 151 East Section of South Second Ring Road, Xi'an, Shaanxi, 710054, China;; 2. Department of Occupational Diseases, Xi'an Central Hospital, 161 West Fifth Road, Xi'an, Shaanxi, 710003, China;; 3. Department of Neurosurgery, the Fifth Medical Centre, Chinese PLA General Hospital, 8 Dongdajie, Beijing, 100071, China;; 4. Department of Neurosurgery, the Eighth Medical Centre, Chinese PLA General Hospital, No. A17, Heishanhu Road, Beijing, 100089, China;; 5. Department of Neurosurgery, the First Medical Centre, Chinese PLA General Hospital, 28 Fuxing Road, Beijing, 100039, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天